Entry Threats and Pricing in the Generic Drug Industry by Federal Trade Commission

Entry Threats and Pricing in the Generic Drug Industry

Federal Trade Commission

30 pages missing pub info (editions)

nonfiction health medium-paced
Powered by AI (Beta)
Loading...

Description

The Federal Trade Commission provides the first analysis of potential competition in the generic drug industry. Our identification strategy exploits a provision of the Hatch-Waxman Act that rewards 180 days of marketing exclusivity to the first ge...

Read more

Community Reviews

Loading...

Content Warnings

Loading...